Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
CVOT trial will help determine if tirzepatide can demonstrate superior cardiovascular safety and potential additional cardiovascular benefits compared to the currently approved GLP-1RA dulaglutide
The discount will vary depending on what type of medication is being prescribed and the dosage
The medication is generally not recommended for individuals with: a personal history of medullary thyroid cancer multiple endocrine neoplasia syndrome type 2 (MEN 2) Although the risk in humans is still being studied, healthcare providers typically evaluate thyroid history before prescribing the medication
In actuarial terms, dedicating 12% of pre-tax income to a single drug is classified as a catastrophic medical expense, severely limiting long-term adherence
Some formulations include synthetic copper peptides , which are lab-engineered versions designed to enhance stability and absorption in skincare products
